Immunosuppressive treatments in MS - Side effects from azathioprine [5]

Journal of Neurology

Volumn 248, Issue 7, 2001, Pages 625-626

  Craner, M J ^a   Zajicek, J P ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; GLATIRAMER; GLUTATHIONE TRANSFERASE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

AZATHIOPRINE; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NAUSEA; PAIN; RETROSPECTIVE STUDIES;

EID: 0034934325     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170145     Document Type: Letter

References (5)

1. Overview of azathioprine treatment in multiple sclerosis
2. Toxic effects of azathioprine in rheumatoid arthritis
3. Azathioprine toxicity during long-term immunosuppression of generalised myasthenia gravis
4. Pharmacogenetics as a molecular basis for individualised drug therapy: The thiopurine S-methyltransferase paradigm
5. Glutathione S-transferase polymorphisms in MS: Their relationship to disability